borderline significancep=0.11
Adherence decreased the risk of death among patients with CTP stage C (HR=0.657, 0.428–1.008, p=0.055) with borderline significance, but not in patients with CTP stages A and B (HR=0.701, 0.452–1.086, p=0.11).
Adherence decreased the risk of death among patients with CTP stage C (HR=0.657, 0.428–1.008, p=0.055) with borderline significance, but not in patients with CTP stages A and B (HR=0.701, 0.452–1.086, p=0.11).